Clinical trials for Vaxart Inc (NASDAQ:VXRT) oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier (8.21) Vaxart has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a …
Continue reading “Is Vaxart Inc (NASDAQ:VXRT) A Buy Or Sell After The Recent Jump?”
The recent developments in the company, makes Vasart Inc. a potential buy for the investors. Vaxart, Inc. (NASDAQ:VXRT) is a clinical-stage biotechnology company which engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The recent news of the company signing a world-wide exclusive licensing agreement with …
Continue reading “Is Vaxart, Inc. (NASDAQ:VXRT) Stock Ready To Cross Above $10 This Month?”
The Vaxart Inc (NASDAQ:VXRT) stock is on the move this morning after the clinical stage biotech firm, involved in the development of oral vaccines, announced that it signed an exclusive global agreement with Altesa Biosciences. The announcement seems to have been welcomed by the market and the Vaxart stock has gone up by 6% this …
Continue reading “Vaxart Inc (VXRT) Stock Gains Momentum: Is it a Breakout Now?”
